Joleen White

Joleen White has a strong background in bioassay development and operations, clinical development, and project management. Joleen'smost recent position was as the Head of Bioassay Development and Operations; Clinical Development at the Bill & Melinda Gates Medical Research Institute. Prior to that, they were the Bioassay Development Lead at the same company.

Before joining the Bill & Melinda Gates Medical Research Institute, Joleen worked at EMD Serono, Inc. Joleen held the position of Director, Head of Project Support NBE DMPK and Associate Director, Project Representative.

Joleen also gained experience at Biogen Idec as a Principal Scientist, Bristol-Myers Squibb as a Group Leader and Senior Research Investigator, and BioMarin Pharmaceutical Inc. as a Senior Scientist. At BioMarin Pharmaceutical Inc., they were responsible for designing and implementing bioanalytical strategies for biopharmaceuticals and developing bioanalytical assays for PK, PD, and immunogenicity analysis.

Earlier in their career, Joleen worked as a Research Scientist at ALZA and as a Scientist at Thios Pharmaceuticals.

Overall, Joleen has a diverse and extensive work experience in the pharmaceutical industry, particularly in the areas of bioassay development, clinical development, project management, and bioanalytical strategies.

Joleen White received a Ph.D. in Macromolecular and Cellular Structure and Chemistry from Scripps Research, where they studied from 1997 to 2002. Prior to that, they earned a B.S. in Chemistry from Harvey Mudd College, attending from 1993 to 1997. Joleen also attended St. Paul's School from 1989 to 1993, graduating magna cum laude. The field of study for their degree at St. Paul's School is not specified.